loader from loading.io

AI’s Impact on the Drug Targeting Process - with Ramesh Durvasula of Lilly

The AI in Business Podcast

Release Date: 11/07/2023

Claims and Underwriting Trends in Personalized Insurance with AI - with Kelly Cusick and Michael Cline of Deloitte show art Claims and Underwriting Trends in Personalized Insurance with AI - with Kelly Cusick and Michael Cline of Deloitte

The AI in Business Podcast

Today’s guests include Kelly Cusick, Managing Director in Deloitte Consulting’s Actual & Insurance Solutions practice, and Michael Cline, Managing Director and Insurance Sector Claims Leader for Deloitte Consulting. Joining Emerj Senior Editor Matthew DeMello, they explain key trends in underwriting for our executive audience, emphasizing the evolution of personalization and the expanding reach of personal connections within the industry. Later in the discussion, the trio explores the transformative impact of new AI capabilities, shedding light on how these technologies enable...

info_outline
AI Opportunities for Life Sciences R&D - with Andrew Bolt of Deloitte show art AI Opportunities for Life Sciences R&D - with Andrew Bolt of Deloitte

The AI in Business Podcast

Today’s guest is Andrew Bolt, Partner at Deloitte. He joins Emerj CEO and Head of Research Daniel Faggella on today’s podcast to talk about challenges in R&D  for life sciences. While productivity has remained stagnant for the last 10-15 years, advances in AI-enhanced protein structure prediction are revolutionizing drug targeting and the very infrastructure of recruiting patients for clinical trials. Later, the two postulate on the ways AI can expedite regulatory compliance in pharmaceutical R&D in similar ways. Find out more about sponsored content and how to engage with the...

info_outline
Developing a Product Mindset in the AI-Driven Enterprise - with Jennifer Bradshaw and Arash Kamiar at NLP Logix show art Developing a Product Mindset in the AI-Driven Enterprise - with Jennifer Bradshaw and Arash Kamiar at NLP Logix

The AI in Business Podcast

Today’s guests on the ‘AI in Business’ podcast are Jennifer Bradshaw and Arash Kamiar, Director of Product and Senior Product Owner at NLP Logix, respectively. NLP Logix is a fast-growing AI services firm based in Florida that serves both the public and private sectors. They join Emerj Senior Matthew DeMello on today’s podcast to talk about developing AI solutions with what they call a ‘product mindset.’ Throughout the program, the pair emphasize shifting focus away from the unique technological capabilities of AI tools to the problems that customers suffer through every day and...

info_outline
Generative AI for Healthcare - with Dr. Dan Elton of Mass General Brigham show art Generative AI for Healthcare - with Dr. Dan Elton of Mass General Brigham

The AI in Business Podcast

Today’s guest is Dr. Dan Elton, a Data Scientist at the Mass General Brigham Data Science Office. He’s also a fellow at the Foresight Institute and previously served as a staff scientist at the National Institutes of Health. He joins Emerj Senior Editor Matthew DeMello on today’s show to talk about promising AI use cases in healthcare, including use cases in radiology, compliance, and medical record generation, search, and summarization. Later, the two discuss how foundational models will transform how AI is used in radiology. To discover more AI use cases, best practice guides, white...

info_outline
Opportunities for AI in Private Equity - with Bhuvanesh Abrol of Deloitte show art Opportunities for AI in Private Equity - with Bhuvanesh Abrol of Deloitte

The AI in Business Podcast

Today's guest is Bhuvanesh Abrol, US Private Equity Consulting Leader and US M&A Services Private Equity Consulting Leader at Deloitte. He joins Emerj CEO and Head of Research Daniel Faggella on today's program to talk about the AI opportunities in private equity investment decisions and deal-making. Later, the pair pull apart the fundamentals of using AI to inform opaque pricing in procurement and to drive increased collection rates. This episode is sponsored by Deloitte. Learn how brands work with Emerj and other Emerj Media options at .

info_outline
The Power of eConsent in Healthcare Workflows - with Melissa Easy and Vinita Navadgi of IQVIA show art The Power of eConsent in Healthcare Workflows - with Melissa Easy and Vinita Navadgi of IQVIA

The AI in Business Podcast

Today’s guests are Melissa Easy, Vice President and General Manager of Clinical Technologies and Vinita Navadgi, Sr. Director, Digital Patient Suite at IQVIA. They join us on today’s show to discuss the advantages of optimizing consent workflows through automation, or ‘eConsent’ processes. The conversation delves into the metrics defining the effectiveness of ‘eConsent’ for both patients and healthcare providers, elucidating the role of AI in shaping the broader landscape of clinical trials. If you’ve enjoyed or benefited from some of the insights of this episode, consider...

info_outline
Automation and Beyond for Sales and Marketing in Life Sciences - with Mark Miller of Deloitte show art Automation and Beyond for Sales and Marketing in Life Sciences - with Mark Miller of Deloitte

The AI in Business Podcast

Today’s guest is Mark Miller, Managing Director of Life Science Advertising, Marketing & Commerce at Deloitte. He joins Emerj CEO and Head of Research Daniel Faggella on today’s podcast to discuss leveraging data in proven AI use cases in pharmaceutical sales and marketing, particularly when it comes to the ‘next best’ engagement. Throughout the episode, Mark emphasizes the importance of connected data and decision algorithms to engage with healthcare professionals more effectively. This episode is sponsored by Deloitte. Learn how brands work with Emerj and other Emerj Media...

info_outline
Innovation and Storytelling in Real Estate - with John D’Angelo of Deloitte show art Innovation and Storytelling in Real Estate - with John D’Angelo of Deloitte

The AI in Business Podcast

Today’s guest is John D’Angelo, Real Estate Solutions Leader at Deloitte. John joins Emerj CEO and Head of Research Daniel Faggella on today’s program to discuss the challenges and trends in the real estate industry, highlighting the local knowledge-heavy nature of the business. Throughout the episode, John emphasizes the true sources of friction to new technology adoption and the importance of storytelling in the sector. Later, the discussion delves into the leasing process, where AI can streamline the creation and understanding of complex leases, reducing labor and mitigating risks....

info_outline
Scaling CX Opportunities in Financial Services - with Ciprian Porutiu of Marsh McLennan show art Scaling CX Opportunities in Financial Services - with Ciprian Porutiu of Marsh McLennan

The AI in Business Podcast

Today’s guest is Ciprian Porutiu, Vice President of Operations and Strategy at Marsh McLennan. Prior to Marsh McLennan, Ciprian spent much of his career in IT leadership for various fintech firms. In conversation with Emerj CEO and Head of Research Daniel Faggella, Ciprian explains the fundamentals of a VUCA – short for volatile, uncertain, complex, and ambiguous – business landscape to a financial services executive audience. Throughout the episode, Ciprian offers insights into delivering the necessary business agility and addressing the acute challenges of scaling systems based on...

info_outline
Creativity and Constraints: A Framework for Responsible Generative AI - with Sreekanth Menon of Genpact show art Creativity and Constraints: A Framework for Responsible Generative AI - with Sreekanth Menon of Genpact

The AI in Business Podcast

Today’s guest is Sreekanth Menon, Vice President and Global Leader of AI/ML Services at Genpact. Sreekanth joins Emerj CEO and Head of Research Daniel Faggella on today’s show for a candid and productive conversation on what responsible AI practices in transparency and accountability truly mean in terms of practical data governance policies. With new generative AI applications and challenges surrounding hallucinations and misinformation, responsible AI disciplines and workflows are no longer the terrain of PR buzzwords. Sreekanth’s appearance on today’s show builds off of Genpact’s...

info_outline
 
More Episodes

Today’s guest is Ramesh Durvasula, Senior Vice President of R&D IT at Lilly. Ramesh joins us on the program today to discuss AI’s impact on the drug targeting process, particularly in helping pharmaceutical leaders like Lilly better predict what potential drugs to invest in for bringing to market and when. With increased certainty in drug targeting, Ramesh explains how AI capabilities are driving clinical trials to be used as an alternative form of healthcare. Visit emerj.com/beg1 to learn more about the practical steps for AI deployment for non-technical professionals.